Articles related to MEDICAL DEVICES

The Sonu Band, now FDA-cleared for children 12+, showed a -2.74 mean TNSS improvement with no adverse events in a 2-week study.

The LAA’s role as the predominant site for thrombus formation in AFib patients positions LAAO as a significant therapeutic approach for stroke prevention.

The Epitomee capsule, a novel ingestible device for weight management, has shown promising results in clinical trials, with 55.5% of users losing at least 5% of their baseline body weight at 24 weeks.

New guidelines endorse the use of continuous glucose monitors and insulin pumps in hospital settings, potentially improving glycemic control while reducing hypoglycemia risk in noncritically ill patients.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.

Advancements in diabetes technology, including CGMs and smart insulin devices, are providing significant benefits in patient care, making it essential for clinicians to stay informed and comfortable with these innovations.